Comparative Effectiveness of Dipeptidylpeptidase-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison Paul CraddyHannah-Jayne PalinK. Ian Johnson Review Open access 25 March 2014 Pages: 1 - 41
The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: a Bench to Bedside Review Janet B. McGill Review Open access 12 April 2014 Pages: 43 - 63
Insulin Degludec Aspart: The First Co-formulation of Insulin Analogues Sanjay Kalra Review Open access 15 May 2014 Pages: 65 - 72
Carcinogenicity Risk Assessment Supports the Chronic Safety of Dapagliflozin, an Inhibitor of Sodium–Glucose Co-Transporter 2, in the Treatment of Type 2 Diabetes Mellitus Timothy P. ReillyMichael J. GrazianoMark Tirmenstein Original Research Open access 29 January 2014 Pages: 73 - 96
Long-term Effects of Mitiglinide in Japanese Diabetics Inadequately Controlled with DPP-4 Inhibitor or Biguanide Monotherapy Kohei KakuNobuya InagakiNaoki Kobayashi Original Research Open access 01 February 2014 Pages: 97 - 111
Safety, Tolerability, and Efficacy of Insulin Aspart in People with Type 2 Diabetes, as Biphasic Insulin Aspart or with Basal Insulin: Findings from the Multinational, Non-Interventional A1chieve Study Issam HajjajiSiddharth ShahPhilip D. Home Original Research Open access 30 January 2014 Pages: 113 - 126
Type 2 Diabetes Mellitus Management and Body Mass Index: Experiences with Initiating Insulin Detemir in the A1chieve Study Mohammed E. KhamsehVinay PrustyAlexey Zilov Original Research Open access 30 January 2014 Pages: 127 - 140
Albiglutide Does Not Prolong QTc Interval in Healthy Subjects: A Thorough ECG Study Borje DarpoMeijian ZhouRickey R. Reinhardt Original Research Open access 08 February 2014 Pages: 141 - 153
Self-Reported Frequency and Impact of Hypoglycemic Events in Spain Domingo Orozco-BeltránPedro Mezquita-RayaManuel Galán Original Research Open access 11 February 2014 Pages: 155 - 168
Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes Mellitus Masato OdawaraIzumi HamadaManabu Suzuki Original Research Open access 07 March 2014 Pages: 169 - 181
Real-Life Effectiveness and Tolerability of Vildagliptin and Other Oral Glucose-Lowering Therapies in Patients with Type 2 Diabetes in Germany Rüdiger GökeGiovanni BaderMarkus Dworak Original Research Open access 19 March 2014 Pages: 183 - 191
Efficacy of Liraglutide in a Real-Life Cohort Anthony HeymannYasmin MaorAvraham Karasik Original Research Open access 25 March 2014 Pages: 193 - 206
Use of Vildagliptin in Management of Type 2 Diabetes: Effectiveness, Treatment Persistence and Safety from the 2-Year Real-Life VILDA Study Dominique SimonBruno DetournaySylvie Dejager Original Research Open access 12 April 2014 Pages: 207 - 224
Early Discontinuation and Restart of Insulin in the Treatment of Type 2 Diabetes Mellitus Haya Ascher-SvanumMaureen J. LageMichael Treglia Original Research Open access 30 April 2014 Pages: 225 - 242
Metabolic Effects of Basal or Premixed Insulin Treatment in 5077 Insulin-Naïve Type 2 Diabetes Patients: Registry-Based Observational Study in Clinical Practice Björn EliassonNils EkströmAnn-Marie Svensson Original Research Open access 15 May 2014 Pages: 243 - 254
Distinct Prandial and Basal Glucose-Lowering Effects of Insulin Degludec/Insulin Aspart (IDegAsp) at Steady State in Subjects with Type 1 Diabetes Mellitus Tim HeiseLeszek NosekHanne Haahr Original Research Open access 03 June 2014 Pages: 255 - 265
Dapagliflozin Added to Glimepiride in Patients with Type 2 Diabetes Mellitus Sustains Glycemic Control and Weight Loss Over 48 Weeks: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial Krzysztof StrojekKun-Ho YoonShamik Parikh Original Research Open access 12 June 2014 Pages: 267 - 283
Sitagliptin Improves the Impaired Acute Insulin Response during a Meal Tolerance Test in Japanese Patients with Type 2 Diabetes Mellitus: A Small-Scale Real-World Study Tsuyoshi OhkuraYouhei FujiokaKazuhiro Yamamoto Original Research Open access 03 June 2014 Pages: 285 - 297
Diabetes Education: the Experiences of Young Adults with Type 1 Diabetes Janice WileyMary WestbrookJeffrey Braithwaite Original Research Open access 12 February 2014 Pages: 299 - 321
Effects of Exenatide in a Morbidly Obese Patient with Type 2 Diabetes Miyako KishimotoMitsuhiko Noda Case Report Open access 18 January 2014 Pages: 323 - 332
Choosing Appropriate Glucagon-like Peptide 1 Receptor Agonists: A Patient-Centered Approach Sanjay Kalra Commentary Open access 19 February 2014 Pages: 333 - 340
Testing the Therapeutic Equivalence of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin or Vildagliptin as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes Andrea MessoriValeria FaddaClaudio Marinai Brief Report Open access 03 May 2014 Pages: 341 - 344
Erratum to: Efficacy of Liraglutide in a Real-Life Cohort Anthony HeymannYasmin MaorAvraham Karasik Erratum Open access 28 May 2014 Pages: 345 - 345